The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Impact of an endothelial progenitor cell capturing stent on coronary microvascular function: comparison with drug-eluting stents

  • Choi, Woong Gil (Division of Cardiology, Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Kim, Soo Hyun (Division of Cardiology, Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Yoon, Hyung Seok (Division of Cardiology, Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Lee, Eun Joo (Division of Cardiology, Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Kim, Dong Woon (Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital)
  • Received : 2014.01.13
  • Accepted : 2014.06.30
  • Published : 2015.01.01
⟨ Previous Next ⟩

Abstract

Background/Aims: Although drug-eluting stents (DESs) effectively reduce restenosis following percutaneous coronary intervention (PCI), they also delay re-endothelialization and impair microvascular function, resulting in adverse clinical outcomes. Endothelial progenitor cell (EPC) capturing stents, by providing a functional endothelial layer on the stent, have beneficial effects on microvascular function. However, data on coronary microvascular function in patients with EPC stents versus DESs are lacking. Methods: Seventy-four patients who previously underwent PCI were enrolled in this study. Microvascular function was evaluated 6 months after PCI based on the index of microvascular resistance (IMR) and the coronary flow reserve (CFR). IMR was calculated as the ratio of the mean distal coronary pressure at maximal hyperemia to the inverse of the hyperemic mean transit time (hTmn). The CFR was calculated by dividing the hTmn by the baseline mean transit time. Results: Twenty-one patients (age, $67.2{\pm}9.6years$; male:female, 15:6) with an EPC stent and 53 patients (age, $61.5{\pm}14.7years$; male:female, 40:13) with second-generation DESs were included in the study. There were no significant differences in the baseline clinical and angiographic characteristics of the two groups. Angiography performed 6 months postoperatively did not show significant differences in their CFR values. However, patients with the EPC stent had a significantly lower IMR than patients with second-generation DESs (median, 25.5 [interquartile range, 12.85 to 28.18] vs. 29.0 [interquartile range, 15.42 to 39.23]; p = 0.043). Conclusions: Microvascular dysfunction was signif icantly improved after 6 months in patients with EPC stents compared to those with DESs. The complete re-endothelialization achieved with the EPC stent may provide clinical benefits over DESs, especially in patients with microvascular dysfunction.

Keywords

References

  1. Topol EJ, Serruys PW. Frontiers in interventional cardiology. Circulation 1998;98:1802-1820. https://doi.org/10.1161/01.CIR.98.17.1802
  2. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008. https://doi.org/10.1056/NEJMoa067193
  3. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937-948. https://doi.org/10.1016/S0140-6736(07)61444-5
  4. Weninger SC, Dunn AJ, Muglia LJ, et al. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc Natl Acad Sci U S A 1999;96:8283-8288. https://doi.org/10.1073/pnas.96.14.8283
  5. Kim JW, Seo HS, Park JH, et al. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction. J Am Coll Cardiol 2009;53:1653-1659. https://doi.org/10.1016/j.jacc.2009.01.051
  6. Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005;46:231-236. https://doi.org/10.1016/j.jacc.2005.01.062
  7. Lim SH, Flammer AJ, Yoon MH, et al. The long-term effect of coronary stenting on epicardial and microvascular endothelial function. Circ Cardiovasc Interv 2012;5:523-529. https://doi.org/10.1161/CIRCINTERVENTIONS.112.970111
  8. Rowland S, Cottone R, Davis HR, et al. Genous bio-engineered R-stent: development, and HEALING clinical evaluations. In: Serruys PW, Gershlick AH, eds. Handbook of Drug-Eluting Stents. London: Taylor & Francis, 2005.
  9. Fearon WF, Balsam LB, Farouque HM, et al. Novel index for invasively assessing the coronary microcirculation. Circulation 2003;107:3129-3132. https://doi.org/10.1161/01.CIR.0000080700.98607.D1
  10. Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation 2006;113:2054-2061. https://doi.org/10.1161/CIRCULATIONAHA.105.603522
  11. de Bruyne B, Bartunek J, Sys SU, Pijls NH, Heyndrickx GR, Wijns W. Simultaneous coronary pressure and flow velocity measurements in humans: feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation 1996;94:1842-1849. https://doi.org/10.1161/01.CIR.94.8.1842
  12. Pijls NH, De Bruyne B, Smith L, et al. Coronary thermodilution to assess flow reserve: validation in humans. Circulation 2002;105:2482-2486. https://doi.org/10.1161/01.CIR.0000017199.09457.3D
  13. Aarnoudse W, Fearon WF, Manoharan G, et al. Epicardial stenosis severity does not affect minimal microcirculatory resistance. Circulation 2004;110:2137-2142. https://doi.org/10.1161/01.CIR.0000143893.18451.0E
  14. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997;96:3390-3395. https://doi.org/10.1161/01.CIR.96.10.3390
  15. Wohrle J, Nusser T, Merkle N, et al. Myocardial perfusion reserve in cardiovascular magnetic resonance: correlation to coronary microvascular dysfunction. J Cardiovasc Magn Reson 2006;8:781-787. https://doi.org/10.1080/10976640600737649
  16. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-1521. https://doi.org/10.1016/S0140-6736(04)17275-9
  17. van Beusekom HM, Ertas G, Sorop O, Serruys PW, van der Giessen WJ. The $Genous^{TM}$ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries. Catheter Cardiovasc Interv 2012;79:231-242. https://doi.org/10.1002/ccd.22928
  18. Fearon WF, Shah M, Ng M, et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2008;51:560-565. https://doi.org/10.1016/j.jacc.2007.08.062
  19. Ng MK, Yong AS, Ho M, et al. The index of microcirculatory resistance predicts myocardial infarction related to percutaneous coronary intervention. Circ Cardiovasc Interv 2012;5:515-522. https://doi.org/10.1161/CIRCINTERVENTIONS.112.969048
  20. Payne AR, Berry C, Doolin O, et al. Microvascular resistance predicts myocardial salvage and infarct characteristics in ST-elevation myocardial infarction. J Am Heart Assoc 2012;1:e002246.
  21. Duckers HJ, Silber S, de Winter R, et al. Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. EuroIntervention 2007;3:67-75.
  22. Beijk MA, Klomp M, Verouden NJ, et al. Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. Eur Heart J 2010;31:1055-1064. https://doi.org/10.1093/eurheartj/ehp476

Cited by

  1. Can improvements in our physiological understanding yield information on the utility of endothelial progenitor cell capture stents? vol.30, pp.1, 2015, https://doi.org/10.3904/kjim.2015.30.1.27
  2. Effects of Catheterization on Artery Function and Health: When Should Patients Start Exercising Following Their Coronary Intervention? vol.49, pp.3, 2015, https://doi.org/10.1007/s40279-019-01055-3